NASDAQ:SBRA - Sabra Health Care REIT Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$23.39 +0.46 (+2.01 %)
(As of 09/20/2018 04:00 PM ET)
Previous Close$22.91
Today's Range$22.75 - $23.39
52-Week Range$15.77 - $23.83
Volume105,193 shs
Average Volume1.03 million shs
Market Capitalization$4.16 billion
P/E Ratio9.40
Dividend Yield7.72%
Beta0.63
Sabra Health Care REIT logoAs of June 30, 2018, Sabra's investment portfolio included 487 real estate properties held for investment (consisting of (i) 352 Skilled Nursing/Transitional Care facilities, (ii) 89 Senior Housing communities (?Senior Housing - Leased?), (iii) 24 Senior Housing communities operated by third-party property managers pursuant to property management agreements (?Senior Housing - Managed?) and (iv) 22 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a direct financing lease, 22 investments in loans receivable (consisting of (i) one mortgage loan, (ii) two construction loans, (iii) one mezzanine loan, (iv) one pre-development loan and (v) 17 other loans), 13 preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing - Managed communities. As of June 30, 2018, Sabra's real estate properties held for investment included 50,030 beds/units and its unconsolidated joint venture included 7,652 beds/units, spread across the United States and Canada.

Receive SBRA News and Ratings via Email

Sign-up to receive the latest news and ratings for SBRA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Real estate investment trusts
Sub-IndustrySpecialized REITs
SectorFinance
SymbolNASDAQ:SBRA
CUSIP78573L10
Phone888-393-8248

Debt

Debt-to-Equity Ratio1.00
Current Ratio3.16
Quick Ratio3.16

Price-To-Earnings

Trailing P/E Ratio9.40
Forward P/E Ratio9.47
P/E Growth2.76

Sales & Book Value

Annual Sales$405.65 million
Price / Sales10.28
Cash Flow$1.5278 per share
Price / Cash15.31
Book Value$19.28 per share
Price / Book1.21

Profitability

EPS (Most Recent Fiscal Year)$2.43
Net Income$158.38 million
Net Margins62.60%
Return on Equity11.21%
Return on Assets5.53%

Miscellaneous

Employees61
Outstanding Shares178,280,000
Market Cap$4.16 billion

Sabra Health Care REIT (NASDAQ:SBRA) Frequently Asked Questions

What is Sabra Health Care REIT's stock symbol?

Sabra Health Care REIT trades on the NASDAQ under the ticker symbol "SBRA."

How often does Sabra Health Care REIT pay dividends? What is the dividend yield for Sabra Health Care REIT?

Sabra Health Care REIT announced a quarterly dividend on Thursday, August 9th. Shareholders of record on Saturday, August 18th will be paid a dividend of $0.45 per share on Friday, August 31st. This represents a $1.80 annualized dividend and a yield of 7.72%. The ex-dividend date of this dividend is Thursday, August 16th. View Sabra Health Care REIT's Dividend History.

How were Sabra Health Care REIT's earnings last quarter?

Sabra Health Care REIT Inc (NASDAQ:SBRA) issued its quarterly earnings results on Wednesday, August, 8th. The real estate investment trust reported $1.08 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.33 by $0.75. The real estate investment trust earned $166.31 million during the quarter, compared to analysts' expectations of $166.62 million. Sabra Health Care REIT had a return on equity of 11.21% and a net margin of 62.60%. View Sabra Health Care REIT's Earnings History.

When is Sabra Health Care REIT's next earnings date?

Sabra Health Care REIT is scheduled to release their next quarterly earnings announcement on Wednesday, November, 7th 2018. View Earnings Estimates for Sabra Health Care REIT.

What price target have analysts set for SBRA?

10 equities research analysts have issued 12-month price targets for Sabra Health Care REIT's stock. Their forecasts range from $19.00 to $26.00. On average, they expect Sabra Health Care REIT's share price to reach $22.6364 in the next year. This suggests that the stock has a possible downside of 2.9%. View Analyst Price Targets for Sabra Health Care REIT.

What is the consensus analysts' recommendation for Sabra Health Care REIT?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sabra Health Care REIT in the last year. There are currently 5 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sabra Health Care REIT.

What are Wall Street analysts saying about Sabra Health Care REIT stock?

Here are some recent quotes from research analysts about Sabra Health Care REIT stock:
  • 1. According to Zacks Investment Research, "Sabra Health Care REIT, Inc. is a real estate investment trust that owns and invests in real estate serving the healthcare industry. The trust owns nursing homes, rehabilitation centers, assisted living facilities, and independent living centers. It leases properties to tenants and operators throughout the United States. Sabra Health Care REIT, Inc. is based in Irvine, California. " (8/2/2018)
  • 2. Cantor Fitzgerald analysts commented, "We rate SBRA $25 price target, based on our expectations for the recently completed combination with CCP, portfolio repositioning, and divestitures, most of which we expect to be completed in 2018. SBRA has an attractive dividend yield of 10.8%, with the company paying out 75% of normalized AFFO. Valuation Summary We arrive at our price target of $25 via a blended average of fair values derived from our DCF model, price/AFFO multiple and Net Asset Value analysis." (6/4/2018)

Who are some of Sabra Health Care REIT's key competitors?

Who are Sabra Health Care REIT's key executives?

Sabra Health Care REIT's management team includes the folowing people:
  • Mr. Richard K. Matros, Chairman, Pres & CEO (Age 64)
  • Mr. Harold W. Andrews Jr., Exec. VP, CFO, Sec. & Principal Accounting Officer (Age 54)
  • Ms. Talya Nevo-Hacohen, Exec. VP, Chief Investment Officer & Treasurer (Age 58)
  • Mr. Peter W. Nyland, Exec. VP of Asset Management
  • Mr. Brent P. Chappell, Exec. VP & Portfolio Mang. (Age 53)

Has Sabra Health Care REIT been receiving favorable news coverage?

Media coverage about SBRA stock has been trending somewhat positive on Thursday, according to Accern. Accern scores the sentiment of press coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Sabra Health Care REIT earned a news and rumor sentiment score of 0.18 on Accern's scale. They also assigned news articles about the real estate investment trust an impact score of 46.57 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near future. View Recent Headlines for Sabra Health Care REIT.

Who are Sabra Health Care REIT's major shareholders?

Sabra Health Care REIT's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.33%), FMR LLC (4.33%), Northern Trust Corp (2.04%), LSV Asset Management (2.03%), Dimensional Fund Advisors LP (1.53%) and Bank of New York Mellon Corp (1.49%). Company insiders that own Sabra Health Care REIT stock include Harold W Jr Andrews and Milton J Walters. View Institutional Ownership Trends for Sabra Health Care REIT.

Which institutional investors are selling Sabra Health Care REIT stock?

SBRA stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Heitman Real Estate Securities LLC, BlackRock Inc., Prosight Management LP, Westpac Banking Corp, Anchor Capital Advisors LLC, Janus Henderson Group PLC and Stevens Capital Management LP. Company insiders that have sold Sabra Health Care REIT company stock in the last year include Harold W Jr Andrews and Milton J Walters. View Insider Buying and Selling for Sabra Health Care REIT.

Which institutional investors are buying Sabra Health Care REIT stock?

SBRA stock was purchased by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Barings LLC, Millennium Management LLC, American Century Companies Inc., Point72 Asset Management L.P., LSV Asset Management, Bank of America Corp DE and Sei Investments Co.. View Insider Buying and Selling for Sabra Health Care REIT.

How do I buy shares of Sabra Health Care REIT?

Shares of SBRA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Sabra Health Care REIT's stock price today?

One share of SBRA stock can currently be purchased for approximately $23.32.

How big of a company is Sabra Health Care REIT?

Sabra Health Care REIT has a market capitalization of $4.16 billion and generates $405.65 million in revenue each year. The real estate investment trust earns $158.38 million in net income (profit) each year or $2.43 on an earnings per share basis. Sabra Health Care REIT employs 61 workers across the globe.

How can I contact Sabra Health Care REIT?

Sabra Health Care REIT's mailing address is 18500 VON KARMAN AVENUE SUITE 550, IRVINE CA, 92612. The real estate investment trust can be reached via phone at 888-393-8248 or via email at [email protected]


MarketBeat Community Rating for Sabra Health Care REIT (NASDAQ SBRA)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  389 (Vote Outperform)
Underperform Votes:  430 (Vote Underperform)
Total Votes:  819
MarketBeat's community ratings are surveys of what our community members think about Sabra Health Care REIT and other stocks. Vote "Outperform" if you believe SBRA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SBRA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel